Literature DB >> 20021322

Therapy-resistant depression.

Tom Bschor1.   

Abstract

Therapy-resistant depression is not untreatable. Numerous treatment methods with substantiated effectiveness exist. However, none of them are able to ensure remission. Thus, what matters when treating therapy-resistant depression is the strict, step-by-step deployment of existing therapeutic options at the right tempo and with a regular systematic evaluation of patient response. Remission should always be the aim, not just some abatement in symptoms (response). The following should be avoided: too small dosages of medication; changing the therapeutic strategy too frequently or too quickly; thoughtlessly sticking to an ineffective treatment over too long a period of time; or unsystematic poly-pharmacy. If these are all avoided than therapy-resistant depressive patients will have a good chance of recovery.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20021322     DOI: 10.1586/ern.09.137

Source DB:  PubMed          Journal:  Expert Rev Neurother        ISSN: 1473-7175            Impact factor:   4.618


  14 in total

1.  [Tricyclic antidepressants for initial treatment of depressive episodes? Pro].

Authors:  T Bschor
Journal:  Nervenarzt       Date:  2016-05       Impact factor: 1.214

2.  High dosage of hypnotics predicts subsequent sleep-related breathing disorders and is associated with worse outcomes for depression.

Authors:  Cheng-Ta Li; Ya-Mei Bai; Ying-Chiao Lee; Wei-Chung Mao; Mu-Hong Chen; Pei-Chi Tu; Ying-Sheue Chen; Tzeng-Ji Chen; Wen-Hang Chang; Tung-Ping Su
Journal:  Sleep       Date:  2014-04-01       Impact factor: 5.849

Review 3.  Combining Antidepressants in Acute Treatment of Depression: A Meta-Analysis of 38 Studies Including 4511 Patients.

Authors:  Jonathan Henssler; Tom Bschor; Christopher Baethge
Journal:  Can J Psychiatry       Date:  2016-01-01       Impact factor: 4.356

4.  Differential modulation of emotion processing brain regions by noradrenergic and serotonergic antidepressants.

Authors:  Annette Beatrix Brühl; Lutz Jäncke; Uwe Herwig
Journal:  Psychopharmacology (Berl)       Date:  2011-02-26       Impact factor: 4.530

Review 5.  Lithium in the treatment of major depressive disorder.

Authors:  Tom Bschor
Journal:  Drugs       Date:  2014-06       Impact factor: 9.546

6.  Lithium monotherapy increases ACTH and cortisol response in the DEX/CRH test in unipolar depressed subjects. A study with 30 treatment-naive patients.

Authors:  Tom Bschor; Dirk Ritter; Patricia Winkelmann; Sebastian Erbe; Manfred Uhr; Marcus Ising; Ute Lewitzka
Journal:  PLoS One       Date:  2011-11-23       Impact factor: 3.240

7.  Bilateral repetitive transcranial magnetic stimulation for treatment-resistant depression: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Y Q Zhang; D Zhu; X Y Zhou; Y Y Liu; B Qin; G P Ren; P Xie
Journal:  Braz J Med Biol Res       Date:  2015-01-13       Impact factor: 2.590

8.  Adverse effects of electroconvulsive therapy on cognitive performance.

Authors:  Sasha S Getty; Lawrence R Faziola
Journal:  Ment Illn       Date:  2017-10-19

9.  Electroconvulsive Therapy Hasn't Negative Effects on Short-Term Memory Function, as Assessed Using a Bedside Hand-Held Device.

Authors:  Helge H O Müller; Mareen Reike; Simon Grosse-Holz; Mareike Röther; Caroline Lücke; Alexandra Philipsen; Johannes Kornhuber; Teja W Grömer
Journal:  Ment Illn       Date:  2017-06-28

10.  Decreased interhemispheric coordination in treatment-resistant depression: a resting-state fMRI study.

Authors:  Wenbin Guo; Feng Liu; Zhimin Xue; Keming Gao; Zhening Liu; Changqing Xiao; Huafu Chen; Jingping Zhao
Journal:  PLoS One       Date:  2013-08-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.